COVID-19 and Cancer: Optimizing Health Communication Through Telemedicine

Authors

  • Anu 1CSIR- National Institute of Science Communication and Policy Research, New Delhi, INDIA.
  • M R Rahman 1CSIR- National Institute of Science Communication and Policy Research, New Delhi, INDIA.
  • NK Prasanna 2Academy of Scientific and Innovative Research, Ghaziabad, INDIA.

DOI:

https://doi.org/10.5530/ctbp.2022.1.11

Keywords:

SARS CoV-2, Cancer, Telemedicine, Health communication, e-consultation, virtual medicine

Abstract

The looming dark cloud of the COVID -19 pandemic refuses to leave us alone even after more than a year. Though healthcare workers have given their best and worked round the clock to combat this deadly virus, large scale and immediate relief is hardly anywhere in sight. This zoonotic virus has unleashed untold misery upon people globally especially on the ageing population with comorbidities. Patients suffering from various forms of cancer had to bear the brunt compounded in manners unforeseen. They were faced with a double-edged challenge to their very existence. Taking timely anticancer therapies and observing the required treatment frequency is one of the major challenges for patients battling cancer. This study attempts to evaluate the impact of COVID-19 on patients with cancer. A noteworthy finding was about telemedicine emerging as a boon for cancer patients in the COVID-19 pandemic times. However, there are several obstacles to overcome, such as accurate prescription interpretation, literacy, and connectivity, to name a few.

Assessed number of cases in 2020, around the world, women, all ages.

Downloads

Published

2022-02-11

How to Cite

Anu, Rahman, M. R., & Prasanna, N. (2022). COVID-19 and Cancer: Optimizing Health Communication Through Telemedicine. Current Trends in Biotechnology and Pharmacy, 16(1), 108–113. https://doi.org/10.5530/ctbp.2022.1.11